Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort.
Valeria Maria PalaClaudia AgnoliAdalberto CavalleriSabina RinaldiRosaria OrlandiFrancesco SegradoElisabetta VenturelliMarco VincetiVittorio KroghSabina SieriPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Our finding that prediagnostic Cu/Zn ratio is a strong risk factor for breast cancer development deserves further investigation and, if confirmed, might open the way to interventions to reduce breast cancer risk in women with disrupted Cu/Zn homeostasis.